Sunlenca 300 mg/1
LENACAPAVIR SODIUM · TABLET, FILM COATED · Gilead Sciences, Inc.
Lenacapavir sodium (Sunlenca) is an oral tablet used to treat HIV infection as part of combination antiretroviral therapy. It belongs to a class of HIV medications that work by blocking viral enzymes needed for the virus to replicate.
Key Facts
- Brand Name
- Sunlenca
- Generic Name
- LENACAPAVIR SODIUM
- NDC Code (Product)
61958-3001- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 300 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215974
- Marketing Start
- 12/22/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Sunlenca used for?
Lenacapavir sodium (Sunlenca) is an oral tablet used to treat HIV infection as part of combination antiretroviral therapy. It belongs to a class of HIV medications that work by blocking viral enzymes needed for the virus to replicate.
Is Sunlenca a controlled substance?
Sunlenca is not classified as a controlled substance by the DEA.
What is the generic name for Sunlenca?
The generic name for Sunlenca is LENACAPAVIR SODIUM. There are 2 other brand versions of LENACAPAVIR SODIUM.
What is the NDC code for Sunlenca 300 mg/1?
The NDC (National Drug Code) for Sunlenca 300 mg/1 is 61958-3001, listed by Gilead Sciences, Inc..